Patent ID: 11938150
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method comprising:
a) administering to a subject who has Amyotrophic Lateral Sclerosis (ALS) a regimen of sodium chlorite; and
b) monitoring a plasma level of C-reactive protein in the subject during the regimen of sodium chlorite and determining based on the monitoring that the plasma level of C-reactive protein in the subject is at least 1125 ng/mL,
wherein the subject is under age 65 and the subject is human;
wherein the subject exhibits a symptom of Amyotrophic Lateral Sclerosis (ALS);
wherein the sodium chlorite is administered in an amount ranging from 0.1 to 10 mg/kg by body weight of the subject;
wherein the administering occurs at least once per month for a period of at least a year; and
wherein the administering occurs over a period ranging from about 0.5 to about 4 hours.